Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

StayHappi Glimepiride+Metformin 3mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Sarvagunaushdhi Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (850mg)

Overview StayHappi Glimepiride+Metformin 3mg/850mg Tablet

DiaBeta (Glimepiride/Metformin 3mg/850mg) tablets are antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication helps manage blood glucose levels. DiaBeta should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical advice can elevate blood sugar, increasing risks of kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol should be avoided due to its hypoglycemic effect. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain is also possible. DiaBeta is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before use. Pregnant or breastfeeding women require medical consultation before starting treatment. Regular blood glucose monitoring and potential blood tests (blood cell counts and liver function) will be recommended by your doctor.

Primary Ingredients of StayHappi Glimepiride+Metformin 3mg/850mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of StayHappi Glimepiride+Metformin 3mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of StayHappi Glimepiride+Metformin 3mg/850mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the StayHappi Glimepiride+Metformin 3mg/850mg tablet whole; do not chew, crush, or divide it. Administer this medication with food.

Common Side effects of StayHappi Glimepiride+Metformin 3mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use StayHappi Glimepiride+Metformin 3mg/850mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for StayHappi Glimepiride+Metformin 3mg/850mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer with food.

How StayHappi Glimepiride+Metformin 3mg/850mg Tablet works:

StayHappi Glimepiride/Metformin 3mg/850mg tablets combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin acts triply: it decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking StayHappi Glimepiride+Metformin 3mg/850mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of StayHappi Glimepiride+Metformin 3mg/850mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Breastfeeding while taking StayHappi Glimepiride+Metformin 3mg/850mg tablets is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm a nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use StayHappi Glimepiride+Metformin 3mg/850mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use StayHappi Glimepiride+Metformin 3mg/850mg Tablets cautiously, potentially requiring dosage modification. Medical consultation is advised. A low starting dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take StayHappi Glimepiride+Metformin 3mg/850mg Tablet :

Should you forget to take a StayHappi Glimepiride+Metformin 3mg/850mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About StayHappi Glimepiride+Metformin 3mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on StayHappi Glimepiride+Metformin 3mg/850mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
StayHappi Glimepiride+Metformin 3mg/850mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue use and seek immediate medical attention.
StayHappi Glimepiride/Metformin 3mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes. This medication improves blood sugar control in adults, complementing diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
StayHappi Glimepiride+Metformin 3mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Long-term use can also result in vitamin B12 deficiency.
Prolonged use of StayHappi Glimepiride+Metformin 3mg/850mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
StayHappi Glimepiride+Metformin 3mg/850mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining StayHappi Glimepiride+Metformin 3mg/850mg tablets with alcohol is unsafe. Alcohol can lower blood sugar, increasing the risk of hypoglycemia and lactic acidosis.
StayHappi Glimepiride+Met...
39
MRP 45
13% off